
Employees
560

People in R&D
22

Revenues 2019
€ 100,7mn

Pharma Clients
80
Doppel
Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.
News & Highlights
Doppel Pharma CDMO delivered the first validation & Commercial batches of Ravidasvir
On March 8th Doppel Pharma CDMO delivered the first validation & Commercial batches of Ravidasvir, to be commercialized in Malaysia for the treatment of Hepatitis C. Hepatitis C is a [...]
Meet Doppel-Dietopack in Berlin on March 30-31 at Pharma Contract Manufacturing.
Rocco Paracchini, CCO at Doppel-Dietopack, will walk you through our Technological and industrial capabilities as applicable to NCE, OTC, GX and nutraceutical (for humans and pets)
Welcome Sotax CE7
We are very proud to welcome Sotax CE7 Smart flow-through dissolution testing system a.k.a #USP IV apparatus or EP Flow-through cell in our labs! Doppel Farmaceutici R&D Unit consolidates his capability in [...]
Environmental KPI
OVERALL SCORE

ENVIRONMENT

LABOR & HUMAN RIGHTS

ETHICS

SUSTAINABLE PROCUREMENT
Corporate history highlights
The company is committed to applying its innovative technologies, deep knowledge and broad experience to develop products of the highest quality for its customers worldwide.
Doppel has a strong track record in building and forging close partnerships with its customers. The company works very closely with its partners to provide high quality services tailored to the specific needs of each individual customer at all stages from formulation, development and manufacturing all the way to marketing and post-marketing controls.
In particular, Doppel provides a specialist consultative service to customers prior to each project in order to determine together the most effective and bespoke solution for the product.